Clinical Trials · NCT05340192
Effect of Octreotide on Saliva
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Duke University
- Enrollment
- 4
- Start date
- Sep 2019
- Locations
- 1 site, United States
- Primary endpoint
- To quantify the change of saliva proteomes of subjects pre-octreotide treatment